
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services is currently experiencing strong financial performance as evidenced by their Q1 results where they exceeded consensus revenue and EBITDA by 12% and 35%, respectively. The company's revenue growth potential is further supported by its potential to begin a return to its more normalized growth algorithm in the future. While there are potential risks and challenges related to their business, the company has a strong track record, and their recent acquisitions could also contribute to their future growth.
Bears say
AMN Healthcare Services is facing headwinds in its language services segment due to competitive pressures, resulting in a decline in revenue and margin. Additionally, the company's labor disruption revenue is expected to plateau in 2026, potentially hampering future growth. Despite positive developments in Nurse and Allied volumes and bill rates, the stock's current valuation, trading at 10.5x and 9.6x next twelve months (NTM) and 2027 EBITDA estimates respectively, is higher than its average forward EBITDA valuation of 11.8x from 2016 to 2019, when the company was not facing pandemic-related challenges.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares